Investigation of the Candidate Tumor Suppressor Gene prk in Prostate Cancer

Abstract

On the basis of the observations that the PLK3 gene is down-regulated or mutated in certain prostate tumor cell lines, as well as other tumors (5;8;9), we hypothesize that PLK3 is a tumor suppressor gene whose inactivation is an important event in the development of prostate cancer. We have proposed to characterize the genetic and epigenetic basis of aberrant PLK3 transcripts detected in prostate cancer, their prevalence and possible clinical relevance, to test the functional ability of PLK3 as a tumor suppressor gene, and to investigate the physiologic function of PLK3 by identification of proteins that interact with PLK3.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Nov 01, 2002
Accession Number
ADA413339

Entities

People

  • David Dai
  • Qi Wang
  • Suqing Xie

Organizations

  • New York Medical College

Tags

DTIC Thesaurus Topics

  • Cell Physiological Processes
  • Cells
  • Chemical Synthesis
  • Chemistry
  • Cytoskeleton
  • Genetics
  • Health Services
  • Medical Personnel
  • Tumor Cell Line

Fields of Study

  • Biology

Readers

  • Molecular and genetic basis of cancer.
  • Neurodegenerative Parkinson's Disease and Rickettsial Disease handbook, including the data level of dopamine, BC, neurons, and PD.

Technology Areas

  • Biotechnology